UK markets close in 5 hours 49 minutes

Nu Skin Enterprises, Inc. (NUS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
12.24-0.23 (-1.84%)
At close: 04:00PM EDT
12.21 -0.03 (-0.25%)
Pre-market: 04:39AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 607.89M
Enterprise value 947.41M
Trailing P/E 72.00
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.31
Price/book (mrq)0.74
Enterprise value/revenue 0.48
Enterprise value/EBITDA 6.82

Trading information

Stock price history

Beta (5Y monthly) 1.10
52-week change 3-68.98%
S&P500 52-week change 321.08%
52-week high 340.68
52-week low 311.84
50-day moving average 312.84
200-day moving average 319.01

Share statistics

Avg vol (3-month) 3809.32k
Avg vol (10-day) 3575.71k
Shares outstanding 549.66M
Implied shares outstanding 649.66M
Float 848.65M
% held by insiders 12.17%
% held by institutions 185.22%
Shares short (15 Apr 2024) 41.61M
Short ratio (15 Apr 2024) 42.19
Short % of float (15 Apr 2024) 44.67%
Short % of shares outstanding (15 Apr 2024) 43.23%
Shares short (prior month 15 Mar 2024) 42.16M

Dividends & splits

Forward annual dividend rate 40.24
Forward annual dividend yield 41.96%
Trailing annual dividend rate 31.56
Trailing annual dividend yield 312.51%
5-year average dividend yield 44.25
Payout ratio 4917.65%
Dividend date 306 Mar 2024
Ex-dividend date 423 Feb 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.44%
Operating margin (ttm)18.78%

Management effectiveness

Return on assets (ttm)4.61%
Return on equity (ttm)1.00%

Income statement

Revenue (ttm)1.97B
Revenue per share (ttm)39.61
Quarterly revenue growth (yoy)-6.50%
Gross profit (ttm)N/A
EBITDA 202.98M
Net income avi to common (ttm)8.6M
Diluted EPS (ttm)0.17
Quarterly earnings growth (yoy)-87.30%

Balance sheet

Total cash (mrq)279.07M
Total cash per share (mrq)5.65
Total debt (mrq)610.59M
Total debt/equity (mrq)74.28%
Current ratio (mrq)2.13
Book value per share (mrq)16.60

Cash flow statement

Operating cash flow (ttm)118.64M
Levered free cash flow (ttm)114.07M